openPR Logo
Press release

Glycated Albumin Market In-depth Research & Key Company Profiles are Lifespan Biosciences, Biomatik Corporation, Abbexa, G Biosciences, DRG International

11-20-2018 04:17 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Clinical Diagnostic Industry

Glycated Albumin

Glycated Albumin

Increasing approval of novel glycated albumin test kits by key players in the market is expected to expand glycated albumin market size in the near future. For instance, in 2017, Japan-based Asahi Kasei Pharma Corporation received 510(k) clearance from the U. S. Food and Drug Administration (FDA) for its new Lucica Glycated Albumin-L, which is an in vitro diagnostic assay kit formulated for the U.S market.

Lucica Glycated Albumin-L is developed for the quantitative measurement of glycated albumin in human serum on compatible clinical chemistry analyzers. The approval of novel glycated albumin test kits from major regulatory bodies is expected to fuel glycated albumin kits/assays market growth over the forecast period.

Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin test, thereby driving growth of the global glycated albumin assays market. For Instance, according to the data published by the World Health Organization (WHO), in 2014, around 8.5% of the adults aged 18 and above accounting around 422 million adults were suffering from diabetes worldwide. According to a survey conducted by the Center for Disease Control and Prevention (CDC), in 2016, over 30.3 million people in the U.S. were diagnosed with diabetes, which accounts for around 9% of the U.S. population. Such high prevalence of diabetes globally will increase the demand for glycated albumin and therefore, is expected to drive the market growth.

Get HOLISTIC Request Sample Copy Of This Business Report:

The global glycated market is expected to exhibit a CAGR of XX% over the forecast period (2018 – 2026), owing to increasing approval of novel glycated albumin kits by major regulatory bodies in the key regions

North America held dominant position in the global glycated albumin market and is expected to retain its dominance over the forecast period (2018 – 2026), owing to the approval of novel glycated albumin test in the region. For instance, in 2017, Asahi Kasei Pharma Corporation received the U.S. Food and Drug Administration 510(k) clearance for its Lucica Glycated Albumin-L, which is an in vitro diagnostic assay kit formulated for the U.S market.

Asia Pacific is expected to witness significant growth over the forecast period due to increasing prevalence of diabetes in emerging economies such as India, Japan, and China. For instance, according to a survey conducted by the National Institute of health (NIH), in 2016, over 62 million people were diagnosed with diabetes in India.

Glycation is the process of bonding of a sugar molecule. For instance, glucose to a protein or a lipid molecule such as albumin. Glycated albumin is glucose bonded to an albumin molecule. Protein molecule i.e. albumin is present in the blood, major body organs, and body fluids. Function of albumin is to maintain shape of the cell and distribute hormones and nutrients.

The amount of albumin decreases in the body when blood glucose levels are low, whereas increases when blood glucose levels are high. Glycated albumin is measured during initiation of diabetes therapies to determine medication dose for treatment of diabetes. According to a study conducted by American Association for Clinical Study, in 2011, glycated albumin is described as a novel biomarker for the detection and management of diabetes. Treatment of diabetes requires glycemic control. There are various measurements used to provide indicators, which include glycated hemoglobin (HbA1c), 1, 5-anhydroglucitol (1,5AG), and glycated albumin.

Download the PDF brochure:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glycated Albumin Market In-depth Research & Key Company Profiles are Lifespan Biosciences, Biomatik Corporation, Abbexa, G Biosciences, DRG International here

News-ID: 1386290 • Views: 245

More Releases from Coherent Market Insights - Clinical Diagnostic Industry

Asia Pacific HIV Diagnostics Market Determined By Market Concentration Rate, New …
HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV includes testing services in health-care facilities, free-standing sites, and a wide range of community-based approaches along with HIV self-testing. Developments such as home testing represent new and major opportunities for addressing HIV among men who have sex with men (MSM). According to the UNAIDS, the Joint United Nations Program on HIV
Precision Medicine Diagnostics Market Innovative Treatments, Key Methodologies, …
Precision medicine aims to alter the treatments based on individual characteristics, including differences in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a variety of diseases. Precision medicine implicate the application of panomic analysis and systems biology to inspect the cause of an individual patient's diseased condition at the molecular level and then to apply targeted treatments to address that individual patient's disease.
Influenza Diagnostics Market: Healthcare Industry to Remain Key End-use; Vital A …
Global Influenza Diagnostics Market, by Test Type (Traditional Diagnostic Test and Molecular Diagnostic Assays), by End User (Hospitals and Clinics, Reference Laboratories, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018- 2026 Download PDF Brochure Of This Research Report @ Influenza (flu) is a contagious disease of the upper respiratory system caused due to
Constipation Treatment Market Insights With Key Players AstraZeneca, Takeda Phar …
Constipation Treatment Market Overview Constipation is a disorder that causes issues related to clearing of the bowels and usually leads to hardened feces. It is especially prevalent among the elderly and women. Common symptoms of constipation include lumpy or hard stools, lower abdominal discomfort, straining to have bowel movements, feeling of blockage in rectum that prevents bowel movements, and infrequent bowel movements. Factor that can lead to constipation are aging, dehydration,

All 5 Releases

More Releases for Glycated

Glycated Hemoglobin Testing Market : Lucrative Opportunities
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Glycated Haemoglobin Testing Market
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated
Latest market Research | Glycated Albumin Sales 2017
This report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated Albumin for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Glycated Albumin market competition by top manufacturers/players, with Glycated Albumin sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including • Asahi Kasei Pharma • DIAZYME • Abnova • LifeSpan • Exocell • BSBE • Medicalsystem • Maccura • Leadman • Simes Sikma • NINGBO PUREBIO On the basis of product, this